Robert A. Wax

Array ( [id] => 782674 [patent_doc_number] => 06991921 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-31 [patent_title] => 'Hyaluronan synthase gene and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/011768 [patent_app_country] => US [patent_app_date] => 2001-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 13 [patent_no_of_words] => 21910 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/991/06991921.pdf [firstpage_image] =>[orig_patent_app_number] => 10011768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6783712 [patent_doc_number] => 20030065160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Secreted protein HEMAE80' [patent_app_type] => new [patent_app_number] => 10/004860 [patent_app_country] => US [patent_app_date] => 2001-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 157657 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20030065160.pdf [firstpage_image] =>[orig_patent_app_number] => 10004860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7464486 [patent_doc_number] => 20040053370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'GLP-1 Fusion Proteins' [patent_app_type] => new [patent_app_number] => 10/433108 [patent_app_country] => US [patent_app_date] => 2003-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 27214 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053370.pdf [firstpage_image] =>[orig_patent_app_number] => 10433108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 462089 [patent_doc_number] => RE039705 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2007-06-26 [patent_title] => 'Method of treating glutathione deficient mammals' [patent_app_type] => reissue [patent_app_number] => 09/994164 [patent_app_country] => US [patent_app_date] => 2001-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3749 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/039/RE039705.pdf [firstpage_image] =>[orig_patent_app_number] => 09994164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1101911 [patent_doc_number] => 06815419 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-09 [patent_title] => 'Antiulcer agent' [patent_app_type] => B1 [patent_app_number] => 09/979319 [patent_app_country] => US [patent_app_date] => 2001-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4552 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/815/06815419.pdf [firstpage_image] =>[orig_patent_app_number] => 09979319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1080952 [patent_doc_number] => 06835815 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-28 [patent_title] => 'Nod2 nucleic acids and proteins' [patent_app_type] => B2 [patent_app_number] => 10/014269 [patent_app_country] => US [patent_app_date] => 2001-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 16 [patent_no_of_words] => 51126 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/835/06835815.pdf [firstpage_image] =>[orig_patent_app_number] => 10014269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1161253 [patent_doc_number] => 06748954 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-15 [patent_title] => 'Drug release from polymer matrices through mechanical stimulation' [patent_app_type] => B2 [patent_app_number] => 09/983320 [patent_app_country] => US [patent_app_date] => 2001-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 4536 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/748/06748954.pdf [firstpage_image] =>[orig_patent_app_number] => 09983320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 993688 [patent_doc_number] => 06916787 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-12 [patent_title] => 'Method for producing hemin proteins using plant cells, resulting proteins and products containing same' [patent_app_type] => utility [patent_app_number] => 10/085853 [patent_app_country] => US [patent_app_date] => 2001-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21677 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/916/06916787.pdf [firstpage_image] =>[orig_patent_app_number] => 10085853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1080381 [patent_doc_number] => 06835539 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-12-28 [patent_title] => 'Nucleic sequences coding for an AT2 interacting proteins interacting with the AT2 receptor and their applications' [patent_app_type] => B1 [patent_app_number] => 09/762194 [patent_app_country] => US [patent_app_date] => 2001-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14190 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/835/06835539.pdf [firstpage_image] =>[orig_patent_app_number] => 09762194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6839165 [patent_doc_number] => 20030036505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'Signal transduction pathway component polynucleotides, polypeptides, antibodies and methods based thereon' [patent_app_type] => new [patent_app_number] => 09/955999 [patent_app_country] => US [patent_app_date] => 2001-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 159745 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20030036505.pdf [firstpage_image] =>[orig_patent_app_number] => 09955999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1147242 [patent_doc_number] => 06774107 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-10 [patent_title] => 'Protein for blocking platelet adhesion' [patent_app_type] => B1 [patent_app_number] => 09/936737 [patent_app_country] => US [patent_app_date] => 2001-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 8146 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/774/06774107.pdf [firstpage_image] =>[orig_patent_app_number] => 09936737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5787261 [patent_doc_number] => 20020160489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Streptococcus equisimilis hyaluronan synthase gene and expression thereof in Bacillus subtilis' [patent_app_type] => new [patent_app_number] => 09/879959 [patent_app_country] => US [patent_app_date] => 2001-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 23008 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160489.pdf [firstpage_image] =>[orig_patent_app_number] => 09879959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5828585 [patent_doc_number] => 20020068351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Human brain phosphodiesterase' [patent_app_type] => new [patent_app_number] => 09/947305 [patent_app_country] => US [patent_app_date] => 2001-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11458 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068351.pdf [firstpage_image] =>[orig_patent_app_number] => 09947305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1092003 [patent_doc_number] => 06824822 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-30 [patent_title] => 'Residual solvent extraction method and microparticles produced thereby' [patent_app_type] => B2 [patent_app_number] => 09/942631 [patent_app_country] => US [patent_app_date] => 2001-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10154 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/824/06824822.pdf [firstpage_image] =>[orig_patent_app_number] => 09942631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 690337 [patent_doc_number] => 07074614 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-11 [patent_title] => 'Clock gene BMAL2' [patent_app_type] => utility [patent_app_number] => 10/467721 [patent_app_country] => US [patent_app_date] => 2001-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 15078 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/074/07074614.pdf [firstpage_image] =>[orig_patent_app_number] => 10467721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7170398 [patent_doc_number] => 20040077837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Microtubule-associated proteins and tubulins' [patent_app_type] => new [patent_app_number] => 10/362247 [patent_app_country] => US [patent_app_date] => 2003-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37110 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077837.pdf [firstpage_image] =>[orig_patent_app_number] => 10362247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6394504 [patent_doc_number] => 20020036154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Solid pharmaceutical dosage formulation of hydrophobic drugs' [patent_app_type] => new [patent_app_number] => 09/925348 [patent_app_country] => US [patent_app_date] => 2001-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4212 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20020036154.pdf [firstpage_image] =>[orig_patent_app_number] => 09925348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1092534 [patent_doc_number] => 06824991 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-30 [patent_title] => 'Human bad polypeptides, encoding nucleic acids and methods of use' [patent_app_type] => B2 [patent_app_number] => 09/922378 [patent_app_country] => US [patent_app_date] => 2001-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8989 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/824/06824991.pdf [firstpage_image] =>[orig_patent_app_number] => 09922378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1071951 [patent_doc_number] => 06841535 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-11 [patent_title] => 'Peptide-mediated transfection agents and methods of use' [patent_app_type] => utility [patent_app_number] => 09/915914 [patent_app_country] => US [patent_app_date] => 2001-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 22 [patent_no_of_words] => 33375 [patent_no_of_claims] => 119 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/841/06841535.pdf [firstpage_image] =>[orig_patent_app_number] => 09915914 [rel_patent_id] =>[rel_patent_doc_number] =>)